ClinicalTrials.gg
CompletedNCT07936123Updated Nov 13, 2026

Virtual Reality Competency-based Simulation Training Improves Early Patient Outcomes in Cataract Surgery

An interventional study of VRST in Surgical Training, sponsored by Copenhagen Academy for Medical Education and Simulation. Completed at 1 site in Denmark. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-13.

Sponsored by Copenhagen Academy for Medical Education and Simulation · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 6 years 3 months after the study started (first participant enrolled Aug 2020, registered Nov 2026).
Updated Nov 13, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
54
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 10 studies in Cataract with a site in Denmark — 2 open to participants now, 2 under way, none of them phase 3. Cataract · Denmark.

Started
2020
the only one that year
No phase
7 of 10
2 open now
Registered
10th of 10
by date
Lead sponsor
1 of 10
Copenhagen Academy for Medical Education and Simulation

Among the 10 studies in Cataract with a site in Denmark, this one is the only one that started in 2020, is one of 7 with no phase, and was the 10th registered.

Cataract

1,632 studies on the registry are indexed under Cataract; 235 are open to participants now.

Browse Cataract studies →

Open to participants now

2 of the 10 studies in Cataract with a site in Denmark are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 142 Cataract studies recruiting now, 88 (62%) set no upper age limit and 8 (6%) stop at 75 or younger; 10 take children under 18; 16 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Cataract with a site in Denmark, or all of them as a file.
02

Study summary

This study investigated the effect of virtual reality simulation training (VRST) on early patient outcomes following cataract surgery performed by novice surgeons. Nine novice cataract surgeons were divided into two groups based on previous VRST experience. Group allocation was determined by regional differences in simulator availability rather than randomization. Each surgeon performed three cataract surgeries before and three after completing competency-based VRST. The primary outcomes were postoperative corneal swelling and best-corrected visual acuity (BCVA), assessed preoperatively and on the first postoperative day. Phacoemulsification energy use was evaluated as a secondary outcome.

Read the detailed description

This study investigated the effect of virtual reality simulation training (VRST) on early patient outcomes following cataract surgery performed by novice surgeons.

Nine novice cataract surgeons, each having performed fewer than ten independent cataract surgeries, were included from three regions in Denmark. Surgeons were divided into two groups based on previous VRST experience: five VRST-naïve surgeons and four VRST-experienced surgeons. Differences in previous VRST experience reflected regional variation in simulator availability, and no randomization was performed.

Each surgeon performed three cataract surgeries before and three after completing VRST on the EyeSi Surgical Simulator. Both groups received the same training intervention. All sur-geons also received standard surgical training and supervision according to routine clinical practice at their respective institutions. These training and supervision practices were not modified as part of the study.

Patients undergoing routine cataract surgery were included in the study. All patients were scheduled to undergo surgery performed by novice surgeons as part of routine clinical prac-tice, independently of study participation. Patients were not allocated to surgeons based on the study protocol, and the study did not alter their planned surgical treatment. The study-specific intervention consisted exclusively of simulation-based training provided to the sur-geons.

Patient outcomes were assessed preoperatively and on the first postoperative day. The pri-mary outcomes were postoperative corneal swelling, measured as the change in central cor-neal thickness from preoperative assessment to the first postoperative day, and best-corrected visual acuity (BCVA), assessed preoperatively and on the first postoperative day. Cumulative dissipated energy (CDE) during phacoemulsification was evaluated as a second-ary outcome.

The study aimed to investigate whether previous VRST experience was associated with dif-ferences in early patient outcomes and whether these differences changed following VRST, particularly among surgeons without previous VRST experience.

03

Conditions studied

  • Surgical Training

Browse trials for

Keywords

  • virtual reality
  • simulation
  • cataract
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Age >18 years.

Capacity to provide .

Scheduled to undergo cataract surgery at the Department of Ophthalmology, Rigshospitalet-Glostrup, Aarhus University Hospital, or Aalborg University Hospital.

Exclusion criteria

Exclusion Criteria:

History of epiretinal membrane.

History of retinal vein occlusion.

History of retinal detachment.

History of uveitis.

Glaucoma.

Diabetes mellitus.

Exudative age-related macular degeneration (AMD) or AMD with geographical atrophy.

Inability to fully cooperate.

Shallow anterior chamber (corneal epithelium to lens \<2.3 mm).

Small pupils requiring anticipated intraoperative use of a Malyugin ring.

Fuchs' endothelial dystrophy, defined as >20 central guttatae and endothelial cell density \<2,000 cells/mm².

Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
54 participants (actual)

Study arms

  • Experimental
    VRST intervention

    All partiicpants regardless of previous virtual reality simulation training experience, received an virtual reality simulation training intervention after the surgeons' first 3 independent cataract operations

    Other: VRST

Interventions

  • OtherVRST

    competency-based virtual reality simulation. The surgeons were required to train on the simulator until they were able to pass a proficiency test on the simulator

06

What researchers measure

Primary outcomes

  1. Postoperative corneal swelling

    central corneal thickness (CCT) measured preoperatively and on the first postoperative day. Corneal swelling is calculated by substracting postoperative CCT from preoperative CCT

    Time frame: 1 day

  2. Best corrected visual acuity (BCVA)

    Measured preoperatively and on the first postoperative day. Part of standard evaluation and checkup on cataract surgical patients. Outcome is the calculated difference between preoperative and postoperative BCVA

    Time frame: 1 day

Secondary outcomes

  1. Cumulative Dissipated Phacoemulsification Energy

    The amount of phacoemulsification energy used during the cataract surgical procedure

    Time frame: N/A measured on the day of the surgery

  2. Intraoperative ocular pressure (IOP)

    IOP measured as part of the standard evaluation of the cataract patient. Measured preoperatively and on the first postoperative day

    Time frame: 1 day

  3. CATQUEST 7SF

    Questionnare of patient satisfaction with his/her vission. The patient filled out the questionnare preoperatively and 3 month postoperatively

    Time frame: 3 months

07

Study locations

1 site
  • Department of ophthalmology
    Glostrup Municipality, Copenhagen 2700, Denmark
08

References and documents

Publications

  • Thomsen AS, Bach-Holm D, Kjaerbo H, Hojgaard-Olsen K, Subhi Y, Saleh GM, Park YS, la Cour M, Konge L. Operating Room Performance Improves after Proficiency-Based Virtual Reality Cataract Surgery Training. Ophthalmology. 2017 Apr;124(4):524-531. doi: 10.1016/j.ophtha.2016.11.015. Epub 2016 Dec 22. PubMed 28017423 ↗
  • Jacobsen MF, Holm LM, Erichsen JH, Konge L, Siersma V, la Cour M, Thomsen ASS. Defining the surgical footprint in cataract surgery: patient-related outcomes dependent on the experience of the surgeon. Acta Ophthalmol. 2021 Nov;99(7):e999-e1005. doi: 10.1111/aos.14733. Epub 2020 Dec 30. PubMed 33377606 ↗

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2020 to primary completion in Nov 2025, 63 months.

Of 303 non-industry interventional studies with no phase under Cataract, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 30. This study's 63 months is above that.

Counting every sponsor, half of 493 studies reached it within 17 months; a quarter within 9 and three quarters within 29.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2026
First posted
Nov 13, 2026
StartActual
Aug 1, 2020
Primary completionActual
Nov 7, 2025
CompletionActual
Dec 1, 2025
Last update
Nov 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 13, 2026
Show all 1 update
  1. Nov 13, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07936123
Lead sponsor
Copenhagen Academy for Medical Education and Simulation
Collaborators
Copenhagen University Hospital, Rigshospitalet
Responsible party
Amalie Carlsson (MD, Copenhagen Academy for Medical Education and Simulation) — Principal investigator
First posted
Nov 13, 2026
Start date
Aug 1, 2020
Primary completion
Nov 7, 2025
Completion
Dec 1, 2025
Last update
Nov 13, 2026

Study contacts

Ann Sofia S Thomsen, MD, PhD
principal investigator · Department of Ophthalmology, Rigshospitalet-Glostrup, Copenhagen, Denmark

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion